Mental healthcare in the U.S. is broken – psychedelics may just save the day

The big picture: While research continues, psychedelic medicine could reshape the future of healthcare and wellness. As momentum builds, scientists, startups, investors, and big pharma are plotting their next move.

Psychedelics-as-a-service. Unlike cannabis, proponents are quick to warn that psychedelics aren’t a commodity, they’re a service. Marijuana is a commodity that can be cultivated and distributed. Psychedelics, on the other hand, rely on delivery — or the service component.